Home » Topics » Briefs » Other news to note

Other news to note
RSS

Vantia Therapeutics raises funds to develop VA-106483 and VA-111913

July 8, 2011

GSK receives approvals in Japan for Rotarix and Lamictal

July 6, 2011

Japanese MHLW approves Merck & Co.'s Gardasil, Zolinza and Cubicin

July 4, 2011

Immune Pharmaceuticals licenses bertilimumab from iCo Therapeutics

July 1, 2011

Cardium Therapeutics to acquire Transdel Pharmaceuticals

June 30, 2011

Compugen validates second candidate based on CD28/B7 costimulatory family

June 29, 2011

FDA grants orphan drug status to Revimmune in systemic sclerosis and autoimmune hemolytic anemia

June 28, 2011

Evotec and Ono continue ion channel drug discovery collaboration

June 28, 2011

FDA approves personalized cell therapy laViv to improve appearance of smile lines

June 23, 2011

Concert Pharmaceuticals advances new drug candidates in kidney disease and spasticity

June 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...